Incidence and predictors of post-reperfusion syndrome in living donor liver transplantation

Clinical Transplantation

Volumn 26, Issue 4, 2012, Pages 539-543

  Chung, In S ^a   Kim, Ha Y ^a   Shin, Young H ^a   Ko, Justin S ^a   Gwak, Mi S ^a   Sim, Woo S ^a   Kim, Gaab S ^a   Lee, Suk Koo ^b  

^a Department of Anesthesiology and Pain Medicine ^*  (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Incidence; Liver transplantation; Living donor; Post reperfusion syndrome; Risk factor

Indexed keywords

BILIRUBIN; HEMOGLOBIN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT STEATOSIS; HEART RATE; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MODEL FOR END STAGE LIVER DISEASE SCORE; OUTCOME ASSESSMENT; POST REPERFUSION SYNDROME; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STEATOSIS; URINE VOLUME; VASCULAR DISEASE;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; INCIDENCE; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REPERFUSION; REPERFUSION INJURY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; SYNDROME;

EID: 84864958073     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01568.x     Document Type: Article

References (24)

1. Ayanoglu HO, Ulukaya S, Tokat Y. Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. Transplant Proc 2003: 35: 1442.
2. Chui AK, Shi L, Tanaka K et al.Postreperfusion syndrome in orthotopic liver transplantation. Transplant Proc 2000: 32: 2116.
3. Girn HR, Ahilathirunayagam S, Mavor AI, Homer-Vanniasinkam S. Reperfusion syndrome: cellular mechanisms of microvascular dysfunction and potential therapeutic strategies. Vasc Endovascular Surg 2007: 41: 277.
4. Moreno C, Sabate A, Figueras J et al.Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: influence of hepatic artery or portal vein revascularization of the graft. Liver Transpl 2006: 12: 1607.
5. Nardo B, Caraceni P, Pasini P et al.Increased generation of reactive oxygen species in isolated rat fatty liver during postischemic reoxygenation. Transplantation 2001: 71: 1816.
6. Nanashima A, Pillay P, Crawford M, Nakasuji M, Verran DJ, Painter D. Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. J Hepatobiliary Pancreat Surg 2001: 8: 557.
7. Paugam-Burtz C, Kavafyan J, Merckx P et al.Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transpl 2009: 15: 522.
8. Hilmi I, Horton CN, Planinsic RM et al.The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 2008: 14: 504.
9. Ko JS, Kim GS, Gwak MS et al.Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation. Transplant Proc 2008: 40: 3308.
10. Shin BS, Ha IH, Kim GS, Gwak MS, Chung IS. The comparison of coagulation status in the cadaveric donor and living-related liver transplantation. Korean J Anesthesiol 2002: 43: 49.
11. Ricciardi R, Foley DP, Quarfordt SH et al.Donor hepatic function: a factor in postreperfusion syndrome. J Gastrointest Surg 2002: 6: 248.
12. Angele MK, Rentsch M, Hartl WH et al.Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 2008: 195: 214.
13. McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007: 246: 940.
14. Soltys K, Dikdan G, Koneru B. Oxidative stress in fatty livers of obese Zucker rats: rapid amelioration and improved tolerance to warm ischemia with tocopherol. Hepatology 2001: 34: 13.
15. Henriksen JH, Moller S. Cardiac and systemic haemodynamic complications of liver cirrhosis. Scand Cardiovasc J 2009: 43: 218.
16. Al-Hamoudi WK. Cardiovascular changes in cirrhosis: pathogenesis and clinical implications. Saudi J Gastroenterol 2010: 16: 145.
17. Siniscalchi A, Dante A, Spedicato S et al.Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Transplant Proc 2010: 42: 1197.
18. De Boer MT, Christensen MC, Asmussen M et al.The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008: 106: 32.
19. Gonwa TA, Goldstein M, Holman M, Husberg BS, Klintmalm GB. Orthotopic liver transplantation and renal function; outcome of hepatorenal syndrome and trial of verapamil for renal protection in nonhepatorenal syndrome. Transplant Proc 1993: 25: 1891.
20. Deschenes M, Belle SH, Krom RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998: 66: 302.
21. Nemes B, Gelley F, Zadori G et al.Outcome of liver transplantation based on donor graft quality and recipient status. Transplant Proc 2010: 42: 2327.
22. Briceno J, Ciria R. Early graft dysfunction after liver transplantation. Transplant Proc 2010: 42: 631.
23. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003: 9: 651.
24. Hashimoto K, Miller C. The use of marginal grafts in liver transplantation. J Hepatobiliary Pancreat Surg 2008: 15: 92.